Dario Amodei says AI will cure cancer and Alzheimer's in a decade. Doctors aren't buying it.

A cure for cancer is small than a decade away, if you ask Anthropic CEO Dario Amodei.

If you ask several in the medicinal community, though, that timeline is a bit ambitious, if not altogether unrealistic.

In a 42-minute IPO roadshow video the business released on Tuesday, Amodei made the audacious prediction that "cancer, Alzheimer's, bosom disease, mental sickness — these volition be relics of the former in, I think, small than a decade."

The assertion that all those diseases, which have bedeviled medicine's finest minds for centuries, volition be abruptly cured by AI riled several AI naysayers and physicians, who took to X to sound their disbelief.

"Curing cancer, Alzheimer's and mental illnesses can certainly advantage from AI. But that is unattainable in fair 10 years," Karl Lauterbach, Germany's erstwhile health minister, stated on X.

"Unclear whether group akin @DarioAmodei cognize so small concerning medication or are deliberately misleading the public," he added.

Melinda B. Chu, an AI medicinal investigator alongside an MD from Saint Louis University, stated Amodei made those predictions fair to stoke hype for the company's IPO.

"Anthropic has done nothing to propose they themselves volition contribute meaningfully to these goals," Chu said.

Rami Elghandour, a biotech executive, stated Amodei's prediction reeks of desperation. "I've taken two companies public. These are insane things to say in an IPO pitch," he said.

Amodei, lengthy prone to waxing poetic concerning how AI could be misused by bad actors, has sought to soften his doomer position by, in part, highlighting AI's possible advantage to medicine.

Anthropic has moved to develop its attain into medication betterment by purchasing multiple biotech startups, including a one-person business focused on evolving treatments for muscular dystrophy.

In an October blog post, the business stated it had "begun medication finding efforts of our own."

The business additionally opened a "wet lab" in the Bay Area to examine how AI innovation can assistance investigation in essential biology, a individual acquainted alongside the matter said.

In an August X post, Amodei stated that the finest way to win complete AI skeptics is for AI companies to "actually cure cancer." In that post, however, he additionally noted that "saying that AI volition cure malignancy is additional a cliché than it is inspiring, and most group think it is deceptive."

With the company's looming IPO, as it seeks to convince investors to buy inventory at a trillion-dollar valuation, Amodei's calculus has apparently shifted.

"I think if we do this right, we can create an age of miracles," Amodei stated in the video.